Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Incyte Corporation
Baylor College of Medicine
Mayo Clinic
Beijing Biotech
Corvus Pharmaceuticals, Inc.
Seagen Inc.
Bristol-Myers Squibb
SecuraBio
Fudan University
Dana-Farber Cancer Institute
Pfizer
Fudan University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group
Fudan University
Fudan University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Karyopharm Therapeutics Inc
Bristol-Myers Squibb
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Taiho Oncology, Inc.
Centre Henri Becquerel
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Chengdu Zenitar Biomedical Technology Co., Ltd
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Haihe Biopharma Co., Ltd.
National Institutes of Health Clinical Center (CC)
Haihe Biopharma Co., Ltd.
Boryung Pharmaceutical Co., Ltd
Seagen Inc.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Aileron Therapeutics, Inc.
Evopoint Biosciences Inc.
Antengene Corporation
Sun Yat-sen University
Dizal Pharmaceuticals
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CellCentric Ltd.
Sun Yat-sen University
Columbia University
Ruijin Hospital
Daiichi Sankyo
Henan Cancer Hospital